Cargando…

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?

Combination chemotherapy used to treat patients with aggressive non-Hodgkin's lymphoma is associated with neutropenia and subsequent infection, hospital admission and treatment delays. Haematopoietic growth factors (HGF) can prevent neutropenia and improve quality of life. We undertook a meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hackshaw, A, Sweetenham, J, Knight, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409679/ https://www.ncbi.nlm.nih.gov/pubmed/15054445 http://dx.doi.org/10.1038/sj.bjc.6601708

Ejemplares similares

Family history of haematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study
por: Lu, Y, et al.
Publicado: (2009)

Risk of non-Hodgkin's lymphoma following tuberculosis
por: Askling, J, et al.
Publicado: (2001)

BRAF mutations in non-Hodgkin's lymphoma
por: Lee, J W, et al.
Publicado: (2003)

Non-Hodgkin Lymphoma (NHL) in Pakistan
por: Pervez, Shahid
Publicado: (2012)

The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma
por: Beard, S M, et al.
Publicado: (2000)

Comparison of the distribution of non-AIDS Kaposi's sarcoma and non-Hodgkin's lymphoma in Europe
por: Maso, L Dal, et al.
Publicado: (1999)

Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin’s Lymphoma
por: QIU, YunMi, et al.
Publicado: (2022)

Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma
por: Leung, W, et al.
Publicado: (2007)

Occupational cancer in Britain: Haematopoietic malignancies: leukaemia, multiple myeloma, non-Hodgkins lymphoma
por: Brown, Terry, et al.
Publicado: (2012)

The value of anti-epileptic therapy as a prophylactic factor for seizures in the management of moderate traumatic brain injury
por: Faropoulos, Konstantinos, et al.
Publicado: (2020)

Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins
por: Cozen, W, et al.
Publicado: (2013)

Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
por: Urru, S. A. M., et al.
Publicado: (2014)

Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Alessa, Mohammed A., et al.
Publicado: (2015)

Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
por: Zhou, Minglong, et al.
Publicado: (2008)

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Induced Severe Atypical Rash in a Patient of Non-Hodgkin's Lymphoma
por: Singh, Gautam Kumar, et al.
Publicado: (2022)

Predictive value of interim PET/CT visual interpretation in the prognosis of patients with aggressive non-Hodgkin’s lymphoma
por: Liao, Cheng-Cheng, et al.
Publicado: (2017)

High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening
por: Greenfield, D M, et al.
Publicado: (2006)

Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment.
por: Sweetenham, J. W., et al.
Publicado: (1989)

Primary Cutaneous Gamma-Delta T-cell Lymphoma: Not an Aggressive Disease in All Cases
por: KHALLAAYOUNE, Mehdi, et al.
Publicado: (2020)

Extranodal large B-cell type aggressive non-Hodgkin's lymphoma
por: Batra, Ranmeet, et al.
Publicado: (2014)

Aggressive squamous cell carcinoma as a harbinger of non-Hodgkin lymphoma
por: Callaghan, Daniel J., et al.
Publicado: (2018)

Blood Epstein–Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma
por: Ul-Haq, Ikram, et al.
Publicado: (2018)

Trials in advanced Hodgkin's disease: asking the right questions at the right time
por: Sweetenham, J
Publicado: (2001)

Detection of toxigenic Clostridium difficile colonization in patients admitted to the hospital for chemotherapy or haematopoietic cell transplantation
por: Vaughn, John L., et al.
Publicado: (2018)

Human rhinovirus C in adult haematopoietic stem cell transplant recipients with respiratory illness
por: Ferguson, Patricia E., et al.
Publicado: (2013)

Human metapneumovirus infection in haematopoietic stem cell transplant recipients: a case series
por: Jethani, Jyoti, et al.
Publicado: (2021)

Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy
por: Dores, G M, et al.
Publicado: (2010)

Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
por: Johnson, P. W., et al.
Publicado: (1993)

18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma
por: Shelly, M. J., et al.
Publicado: (2012)

The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock
por: West, A C, et al.
Publicado: (2016)

Identification of Novel Insertions and Deletions in Haematopoietic Stem/Progenitor Cells in de novo Myelodysplastic Syndromes
por: Bandara, Manoj, et al.
Publicado: (2021)

Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma
por: Primerano, Simona, et al.
Publicado: (2016)

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma
por: Kang, Ka-Won, et al.
Publicado: (2018)

Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma
por: Husby, Trine, et al.
Publicado: (2022)

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
por: Caimi, Paolo F., et al.
Publicado: (2021)

A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma
por: Marcus, R, et al.
Publicado: (2010)

Seroprevalence of Epstein-Barr virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among patients with non-Hodgkin's lymphoma at the Yaounde General Hospital, Cameroon
por: Bikoï, Jacky Njiki, et al.
Publicado: (2022)

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
por: Lynch, Ryan C., et al.
Publicado: (2022)

Dual targeting of PI3K and BCL‐2 overcomes ibrutinib resistance in aggressive mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2022)

Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective
por: Sheikh, Irtiza N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ho0ljnremal812qnh726tflb1e